Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan(®) Retard) Compared with Other Formulations in Healthy Volunteers

INTRODUCTION: Ambroxol is used in the treatment of acute and chronic respiratory conditions characterized by abnormal mucus secretion and impaired mucus transport and is available in a variety of formulations. This study aimed to compare the steady-state (SS) pharmacokinetic characteristics of exten...

Descripción completa

Detalles Bibliográficos
Autores principales: Ollier, Celine, Sent, Ulrike, Mesquita, Margarida, Michel, Martin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229136/
https://www.ncbi.nlm.nih.gov/pubmed/32372294
http://dx.doi.org/10.1007/s41030-020-00116-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229136/
https://www.ncbi.nlm.nih.gov/pubmed/32372294
http://dx.doi.org/10.1007/s41030-020-00116-7

Ejemplares similares